Brandt Walter Kucharski, the Chief Accounting Officer of $LIFE, sold 499 shares of the company on 05-15-2026 for an estimated $11,307. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.3% of their shares of this class of stock. Following this trade, they now own 183,430 shares of this class of $LIFE stock.
$LIFE Insider Trading Activity
$LIFE insiders have traded $LIFE stock on the open market 13 times in the past 6 months. Of those trades, 3 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $LIFE stock by insiders over the last 6 months:
- 2017 GP, L.L.C. GV has made 0 purchases and 2 sales selling 1,845,308 shares for an estimated $35,060,852.
- ROELOF BOTHA purchased 260,525 shares for an estimated $4,949,975
- WILLIAM J WHEELER purchased 260,525 shares for an estimated $4,949,975
- VIPUL SHARMA (Chief Technology Officer) sold 200,000 shares for an estimated $3,572,000
- 2019 GP, L.L.C. GV has made 0 purchases and 3 sales selling 147,552 shares for an estimated $3,459,808.
- ERIN N LANTZ (Chief Revenue Officer) sold 162,677 shares for an estimated $2,905,411
- BRANDT WALTER KUCHARSKI (Chief Accounting Officer) has made 0 purchases and 3 sales selling 18,251 shares for an estimated $350,399.
- MARK W. MULLIN purchased 5,263 shares for an estimated $99,997
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$LIFE Hedge Fund Activity
We have seen 57 institutional investors add shares of $LIFE stock to their portfolio, and 0 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALPHABET INC. added 3,770,156 shares (+inf%) to their portfolio in Q1 2026, for an estimated $42,112,642
- SOFTBANK GROUP CORP. added 3,128,902 shares (+inf%) to their portfolio in Q1 2026, for an estimated $34,949,835
- CAPITAL WORLD INVESTORS added 1,315,789 shares (+inf%) to their portfolio in Q1 2026, for an estimated $14,697,363
- GLADE BROOK CAPITAL PARTNERS LLC added 1,143,814 shares (+inf%) to their portfolio in Q1 2026, for an estimated $12,776,402
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND added 700,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $7,819,000
- GOLDMAN SACHS GROUP INC added 492,498 shares (+inf%) to their portfolio in Q1 2026, for an estimated $5,501,202
- UBS GROUP AG added 463,853 shares (+inf%) to their portfolio in Q1 2026, for an estimated $5,181,238
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$LIFE Analyst Ratings
Wall Street analysts have issued reports on $LIFE in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citizens issued a "Market Outperform" rating on 02/23/2026
- Goldman Sachs issued a "Buy" rating on 02/23/2026
- Baird issued a "Outperform" rating on 02/23/2026
- B of A Securities issued a "Buy" rating on 02/23/2026
- William Blair issued a "Outperform" rating on 02/23/2026
To track analyst ratings and price targets for $LIFE, check out Quiver Quantitative's $LIFE forecast page.
$LIFE Price Targets
Multiple analysts have issued price targets for $LIFE recently. We have seen 9 analysts offer price targets for $LIFE in the last 6 months, with a median target of $21.0.
Here are some recent targets:
- Ross Sandler from Barclays set a target price of $27.0 on 05/08/2026
- Matthew J. Carletti from Citizens set a target price of $27.0 on 05/07/2026
- Ronald Josey from Citigroup set a target price of $16.0 on 02/26/2026
- Lee Horowitz from Deutsche Bank set a target price of $23.0 on 02/24/2026
- Eric Sheridan from Goldman Sachs set a target price of $33.0 on 02/23/2026
- Colin Sebastian from Baird set a target price of $18.0 on 02/23/2026
- Michael McGovern from B of A Securities set a target price of $15.0 on 02/23/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
